SCHEMBL873654

SCHEMBL873654

C=COc1cccc(OCBr)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAOB P27338 8/20 0.34
BCHE P06276 2/20 0.33
LMNA P02545 1/20 0.33
MAOA P21397 1/20 0.32
THRB P10828 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252848 0.83 ALDH1A1 (0.36) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL1770370 0.83 TP53 (0.50) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL13721564 0.77 MAOB (0.62) ALDH1A1KDM4EMAOBBCHEMAOA
SCHEMBL7527524 0.74 TP53 (0.38) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL5307452 0.74 MAOB (0.58) ALDH1A1CYP3A4TSHRKDM4EMAOB
SCHEMBL13480728 0.74 ACHE (0.50) ALDH1A1CYP3A4SMN1; SMN2MAOBLMNA
SCHEMBL5831450 0.74 MAOB (0.46) ALDH1A1KDM4EKMT2AL3MBTL1MAOB
SCHEMBL17063021 0.73 CYP1A1 (0.41) CYP3A4MAOB
SCHEMBL16180189 0.72 HTR2C (0.47) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2
SCHEMBL22345190 0.71 APP (0.43) ALDH1A1TP53CYP3A4TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP disclosed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO disclosed